Skip to main content
Top
Published in: Lung 6/2018

01-12-2018 | COPD

Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm)

Authors: Xia Wei, Qi Ding, Nan Yu, Jiuyun Mi, Jingting Ren, Jie Li, Shudi Xu, Yanzhong Gao, Youmin Guo

Published in: Lung | Issue 6/2018

Login to get access

Abstract

Purpose

The purpose of the study was to investigate the quantitative chest tomographic features of chronic bronchitis with preserved ratio and impaired spirometry (PRISm), including airway wall area, emphysema index, and lung capacity.

Methods

An observational, cross-sectional study of 343 patients at the Ninth Hospital of Xi’an Affiliated Hospital of Xi’an Jiaotong University between October 2014 and September 2017. The patients were divided into three groups: 77 cases of chronic bronchitis with normal lung function (forced expiratory volume in one second/forced vital capacity) (FEV1/FVC > 70%, FEV1%pred > 80%), 80 cases of chronic bronchitis with PRISm (FEV1/FVC > 70%, FEV1%pred < 80%), and 186 cases of the early chronic obstructive pulmonary disease (COPD) (FEV1/FVC < 70%, FEV1%pred > 50%, that is, Global Initiative for Chronic Obstructive Lung Disease (GOLD) grade 1 + 2). We compared and analyzed the differences in imaging between the chronic bronchitis with PRISm and the other two groups.

Results

Compared with the early COPD group, the PRISm group revealed significant differences in airway wall area, emphysema index, and lung capacity (P < 0.05). Compared with the chronic bronchitis with normal lung function group, the PRISm group showed increased WA%LUL5, decreased lung capacity, and higher mean lung density.

Conclusion

In terms of airway wall area and emphysema index, patients with chronic bronchitis with PRISm were essentially no different than those with chronic bronchitis without abnormal spirometry, whereas for symptoms, they are more like GOLD 1 and 2 patients. Our findings show that it is not yet clear whether it constitutes an intermediate stage of chronic bronchitis with normal lung function that progression to early COPD.
Literature
1.
go back to reference Yin P, Wang H, Vos T, Li Y, Liu S, Liu Y, Liu J, Wang L, Naghavi M, Murray CJ, Zhou M (2016) A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013. Chest 150:1269–1280CrossRef Yin P, Wang H, Vos T, Li Y, Liu S, Liu Y, Liu J, Wang L, Naghavi M, Murray CJ, Zhou M (2016) A subnational analysis of mortality and prevalence of COPD in China from 1990 to 2013. Chest 150:1269–1280CrossRef
2.
go back to reference Liu S, Zhou Y, Liu S, Chen X, Zou W, Zhao D, Li X, Pu J, Huang L, Chen J, Li B, Liu S, Ran P (2016) Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Thorax 72:788–795CrossRef Liu S, Zhou Y, Liu S, Chen X, Zou W, Zhao D, Li X, Pu J, Huang L, Chen J, Li B, Liu S, Ran P (2016) Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Thorax 72:788–795CrossRef
3.
go back to reference Tiffeneau R, Pinelli A (1947) Air circulant et air captif dans l’exploration de la fonction ventilatrice pulmonaire. Paris Med 37:624–628PubMed Tiffeneau R, Pinelli A (1947) Air circulant et air captif dans l’exploration de la fonction ventilatrice pulmonaire. Paris Med 37:624–628PubMed
4.
go back to reference Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI, ECLIPSE Investigators (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365:1184–1192CrossRef Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, Calverley PM, Celli B, Coxson HO, Crim C, Lomas DA, MacNee W, Miller BE, Silverman EK, Tal-Singer R, Wouters E, Rennard SI, ECLIPSE Investigators (2011) Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med 365:1184–1192CrossRef
5.
go back to reference Iyer VN, Schroeder DR, Parker KO, Hyatt RE, Scanlon PD (2011) The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest 139:878–886CrossRef Iyer VN, Schroeder DR, Parker KO, Hyatt RE, Scanlon PD (2011) The nonspecific pulmonary function test: longitudinal follow-up and outcomes. Chest 139:878–886CrossRef
6.
go back to reference Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, Beaty TH, Han MK, Curtis JL, Curran-Everett D, Lynch DA, DeMeo DL, Crapo JD, Silverman EK, COPDGene Investigators (2014) Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res 15:89CrossRef Wan ES, Castaldi PJ, Cho MH, Hokanson JE, Regan EA, Make BJ, Beaty TH, Han MK, Curtis JL, Curran-Everett D, Lynch DA, DeMeo DL, Crapo JD, Silverman EK, COPDGene Investigators (2014) Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res 15:89CrossRef
7.
go back to reference Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD (2010) Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 65:499–504CrossRef Guerra S, Sherrill DL, Venker C, Ceccato CM, Halonen M, Martinez FD (2010) Morbidity and mortality associated with the restrictive spirometric pattern: a longitudinal study. Thorax 65:499–504CrossRef
8.
go back to reference Mannino DM, Holguin F, Pavlin BI, Ferdinands JM (2005) Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis 9:613–621PubMed Mannino DM, Holguin F, Pavlin BI, Ferdinands JM (2005) Risk factors for prevalence of and mortality related to restriction on spirometry: findings from the First National Health and Nutrition Examination Survey and follow-up. Int J Tuberc Lung Dis 9:613–621PubMed
9.
go back to reference Vaz Fragoso CA, Gill TM, McAvay G, Yaggi HK, Van Ness PH, Concato J (2011) Respiratory impairment and mortality in older persons: a novel spirometric approach. J Investig Med 59:1089–1095CrossRef Vaz Fragoso CA, Gill TM, McAvay G, Yaggi HK, Van Ness PH, Concato J (2011) Respiratory impairment and mortality in older persons: a novel spirometric approach. J Investig Med 59:1089–1095CrossRef
10.
go back to reference Mannino DM, Ford ES, Redd SC (2003) Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 114:758–762CrossRef Mannino DM, Ford ES, Redd SC (2003) Obstructive and restrictive lung disease and markers of inflammation: data from the Third National Health and Nutrition Examination. Am J Med 114:758–762CrossRef
11.
go back to reference Diaz AA, Strand M, Coxson HO, Ross JC, San Jose Estepar R, Lynch D, van Rikxoort EM, Rosas IO, Hunninghake GM, Putman RK, Hatabu H, Yen A, Kinney GL, Hokanson JE, Silverman EK, Crapo J, Washko GR (2017) Disease severity dependence of the longitudinal association between CT lung density and lung function in smokers. Chest 153:638–645CrossRef Diaz AA, Strand M, Coxson HO, Ross JC, San Jose Estepar R, Lynch D, van Rikxoort EM, Rosas IO, Hunninghake GM, Putman RK, Hatabu H, Yen A, Kinney GL, Hokanson JE, Silverman EK, Crapo J, Washko GR (2017) Disease severity dependence of the longitudinal association between CT lung density and lung function in smokers. Chest 153:638–645CrossRef
12.
go back to reference Hogg JC (2012) A pathologist’s view of airway obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:5–7CrossRef Hogg JC (2012) A pathologist’s view of airway obstruction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 186:5–7CrossRef
13.
go back to reference Coxson HO, Leipsic J, Parraga G, Sin DD (2014) Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. Am J Respir Crit Care Med 190:135–144CrossRef Coxson HO, Leipsic J, Parraga G, Sin DD (2014) Using pulmonary imaging to move chronic obstructive pulmonary disease beyond FEV1. Am J Respir Crit Care Med 190:135–144CrossRef
14.
go back to reference Barr RG, Berkowitz EA, Bigazzi F et al (2012) A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD 9:151–159CrossRef Barr RG, Berkowitz EA, Bigazzi F et al (2012) A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. COPD 9:151–159CrossRef
15.
go back to reference Thomsen LH, Shaker SB, Dirksen A, Pedersen JH, Tal-Singer R, Bakke P, Vestbo J (2015) Correlation between emphysema and lung function in healthy smokers and smokers with COPD. Chronic Obstr Pulm Dis 2:204–213PubMedPubMedCentral Thomsen LH, Shaker SB, Dirksen A, Pedersen JH, Tal-Singer R, Bakke P, Vestbo J (2015) Correlation between emphysema and lung function in healthy smokers and smokers with COPD. Chronic Obstr Pulm Dis 2:204–213PubMedPubMedCentral
16.
go back to reference Haruna A, Muro S, Nakano Y, Ohara T, Hoshino Y, Ogawa E, Hirai T, Niimi A, Nishimura K, Chin K, Mishima M (2010) CT Scan findings of emphysema predict mortality in COPD. Chest 138:635–640CrossRef Haruna A, Muro S, Nakano Y, Ohara T, Hoshino Y, Ogawa E, Hirai T, Niimi A, Nishimura K, Chin K, Mishima M (2010) CT Scan findings of emphysema predict mortality in COPD. Chest 138:635–640CrossRef
17.
go back to reference Wei X, Ma Z, Yu N, Ren J, Jin C, Mi J, Shi M, Tian L, Gao Y, Guo Y (2018) Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD. Int J Chronic Obstr Pulm Dis 13:121–129CrossRef Wei X, Ma Z, Yu N, Ren J, Jin C, Mi J, Shi M, Tian L, Gao Y, Guo Y (2018) Risk factors predict frequent hospitalization in patients with acute exacerbation of COPD. Int J Chronic Obstr Pulm Dis 13:121–129CrossRef
18.
go back to reference Pu J, Fuhrman C, Good WF, Sciurba FC, Gur D (2011) A differential geometric approach to automated segmentation of human airway tree. IEEE Trans Med Imaging 30:266–278CrossRef Pu J, Fuhrman C, Good WF, Sciurba FC, Gur D (2011) A differential geometric approach to automated segmentation of human airway tree. IEEE Trans Med Imaging 30:266–278CrossRef
19.
go back to reference Yu N, Xin X-M, Li Y, Ma JC, Gao J, Jin CW, Guo YM (2015) Effect of computed tomography dose on quantitative measurement and automated segmentation of airway tree. J Med Imaging Health Inform 5:1519–1523CrossRef Yu N, Xin X-M, Li Y, Ma JC, Gao J, Jin CW, Guo YM (2015) Effect of computed tomography dose on quantitative measurement and automated segmentation of airway tree. J Med Imaging Health Inform 5:1519–1523CrossRef
20.
go back to reference Pu J, Leader JK, Zheng B, Knollmann F, Fuhrman C, Sciurba FC, Gur D (2009) A computational geometry approach to automated pulmonary fissure segmentation in CT examinations. IEEE Trans Med Imaging 28:710–719CrossRef Pu J, Leader JK, Zheng B, Knollmann F, Fuhrman C, Sciurba FC, Gur D (2009) A computational geometry approach to automated pulmonary fissure segmentation in CT examinations. IEEE Trans Med Imaging 28:710–719CrossRef
21.
go back to reference Pu J, Zheng B, Leader JK, Fuhrman C, Knollmann F, Klym A, Gur D (2009) Pulmonary lobe segmentation in CT examinations using implicit surface fitting. IEEE Trans Med Imaging 28:1986–1996CrossRef Pu J, Zheng B, Leader JK, Fuhrman C, Knollmann F, Klym A, Gur D (2009) Pulmonary lobe segmentation in CT examinations using implicit surface fitting. IEEE Trans Med Imaging 28:1986–1996CrossRef
22.
go back to reference Burgel PR (2011) The role of small airways in obstructive airway diseases. Eur Respir Rev 20:23–33CrossRef Burgel PR (2011) The role of small airways in obstructive airway diseases. Eur Respir Rev 20:23–33CrossRef
23.
go back to reference McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Paré PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365:1567–1575CrossRef McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Paré PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC (2011) Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365:1567–1575CrossRef
Metadata
Title
Imaging Features of Chronic Bronchitis with Preserved Ratio and Impaired Spirometry (PRISm)
Authors
Xia Wei
Qi Ding
Nan Yu
Jiuyun Mi
Jingting Ren
Jie Li
Shudi Xu
Yanzhong Gao
Youmin Guo
Publication date
01-12-2018
Publisher
Springer US
Published in
Lung / Issue 6/2018
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-018-0162-2

Other articles of this Issue 6/2018

Lung 6/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.